<i>Saccharomyces boulardii</i>
            administration can inhibit the formation of gastric lymphoid follicles induced by
            <i>Helicobacter suis</i>
            infection

Yang, Lin; Tian, Ziqiang; Yu, Yang; Zhang, Cuiping; Li, Xiaoyü; Mao, Tao; Xue, Jie; WenJun, Zhao; Ding, Xiaobo; Yang, Ronghua; Zhang, Shuaiqing

doi:10.1093/femspd/ftx006

Cited by 9 publications

(10 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…) because it is able to inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection (Yang et al . ).…”

Section: Probiotics Implications Of S Boulardii In Human Healthmentioning

confidence: 97%

“…Its efficiency has been documented in several clinical studies (Czerucka et al 2007;Hatoum et al 2012;Lobato et al 2015). Moreover, probiotic yeasts have been used to alleviate the side effects of treatments against Helicobacter pylori, a gastritis-causing bacteria (Profir et al 2015) because it is able to inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection (Yang et al 2017).…”

Section: Probiotics Implications Of S Boulardii In Human Healthmentioning

confidence: 99%

See 1 more Smart Citation

Application ofSaccharomyces cerevisiae var. boulardiiin food processing: a review

et al. 2018

View full text Add to dashboard Cite

Probiotics are increasingly being added to food in order to develop products with health-promoting properties. Particularly, Saccharomyces cereviceae var. boulardii yeast is recently being investigated like a starting-culture for development of functional and probiotic foods. Although the literature is abundant on the beneficial effects of S. boulardii on health, slight information is available on the effects of supplementing this probiotic to food systems. The aim of this paper is to examine the applications of S. boulardii to different food matrices and its implication in food processing (stability, sensorial properties and other technological implications) and the concomitant effects on nutrition and health.

show abstract

“…) because it is able to inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection (Yang et al . ).…”

Section: Probiotics Implications Of S Boulardii In Human Healthmentioning

confidence: 97%

Section: Probiotics Implications Of S Boulardii In Human Healthmentioning

confidence: 99%

Application ofSaccharomyces cerevisiae var. boulardiiin food processing: a review

et al. 2018

View full text Add to dashboard Cite

show abstract

“…In a murine model of Helicobacter infection using a close species of H. pylori ( H. suis ), S. boulardii decreased the Helicobacter bacterial load, inhibited the formation of lymphoid follicles and reduced expression levels of inflammatory cytokines and chemokines in the stomach. It also increased the production of anti-helicobacter specific IgA and sIgA and beta-defensin in the small intestine after the infection [47].…”

Section: Preclinical-studies: Effects On Enteropathogenic Microorganismsmentioning

confidence: 99%

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections

Czerucka

Rampal

2019

WJG

View full text Add to dashboard Cite

The yeast Saccharomyces boulardii CNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. Studies conducted in vivo and in vitro demonstrated that in the case of infectious diseases there are two potential sites of action of Saccharomyces boulardii CNCM I-745: (1) An action on enteropathogenic microorganisms (adhesion of bacteria and their elimination or an effect on their virulence factors: Toxins, lipopolysaccharide, etc .); and (2) a direct action on the intestinal mucosa (trophic effects, effects on epithelial reconstitution, anti-secretory effects, anti-inflammatory, immunomodulators). Oral administration of Saccharomyces boulardii CNCM I-745 to healthy subjects does not alter their microbiota. However, in the case of diseases associated with the use of antibiotics or chronic diarrhea, Saccharomyces boulardii CNCM I-745 can restore the intestinal microbiota faster. The interaction of Saccharomyces boulardii CNCM I-745 with the innate immune system have been recently demonstrated thus opening up a new therapeutic potential of this yeast in the case of diseases associated with intestinal infections but also other pathologies associated with dysbiosis such as inflammatory diseases.

show abstract

“…Probiotics can benefit the human healthy by regulating the immune function and medicating the normal functional activities, especially in the gastrointestinal tract [10]. The potential molecular mechanism may be involved in the anti-oxidative and anti-inflammatory activities which are able to protect the gastric mucosa, suppress the inflammatory and immune response and rebalance the micro ecosystem after Hp infection [11]. Seen from this, the combination of probiotics and the standard Hp eradication regimen may improve the Hp eradication rate [12].…”

Section: Discussionmentioning

confidence: 99%

Probiotics improved the effectiveness and safety of the quadruple Helicobacter pylori eradication therapy

Jiang¹,

Zhu²

2018

biomedicalresearch

View full text Add to dashboard Cite

Background: Helicobacter pylori (Hp) infection was prevalent all over the world, but the Hp eradication rate remained low. This randomized controlled double blinded study aimed investigated the effectiveness and safety of probiotics combined with the standard regimen in eradicating Hp infection. Methods: Consecutive adult patients who had C14 breath test positivity (>100) and endoscopically diagnosed as chronic active gastritis or gastric ulcer were enrolled and randomized into control group (n=111) and experimental group (n=111). Demographic and clinical characteristics were recoded. The Hp eradication rate and adverse events were compared between two groups. Results: The demographic and clinical characteristics were comparable between the control and experimental group (all P values>0.05). The effectiveness rate of control group was 84.7%, which was obviously lower than that of the experimental group (84. 7% vs. 94.6%, P=0.041). The total incidence of the adverse events in control group was also statistically higher than that in experimental group (P=0.023). There were no statistically significant differences on the rate of taste disorders and anorexia between the two groups (P>0.05). The incidences of abdominal distension, diarrhoea and constipation in control group were greatly higher than those in experimental group (all P values<0.05). Conclusion: These findings proved that the probiotics can improve the effectiveness and safety of the standard Hp eradication regimen.

show abstract

Saccharomyces boulardii administration can inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection

Cited by 9 publications

References 38 publications

Application ofSaccharomyces cerevisiae var. boulardiiin food processing: a review

Application ofSaccharomyces cerevisiae var. boulardiiin food processing: a review

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections

Probiotics improved the effectiveness and safety of the quadruple Helicobacter pylori eradication therapy

Contact Info

Product

Resources

About